Docking studies towards exploring antiviral compounds against envelope protein of yellow fever virus
- 258 Downloads
Yellow fever is among one of the most lethal viral diseases for which approved antiviral therapies were yet to be discovered. Herein, functional assignment of complete YFV proteome was done through support vector machine. Major envelope (E) protein that mediates entry of YFV into host cell was selected as a potent molecular target. Three dimensional structure of the molecular target was predicted using Modeller9v7. The model was optimized in Maestro9.0 applying OPLS AA force field and was evaluated using PROCHECK, ProSA, ProQ and Profile 3D. The BOG pocket residues Val48, Glu197, Thr200, Ile204, Thr265, Thr268 and Gly278 were located in YFV E protein using SiteMap2.3. More than one million compounds of Ligandinfo Meta database were explored using a computational virtual screening protocol targeting BOG pocket of the E protein. Finally, ten top ranked lead molecules with strong binding affinity to BOG pocket of YFV E protein were identified based on XP Gscore. Drug likeliness and comparative bioactivity analysis for these leads using QikProp3.2 had shown that these molecules would have the potential to act as better drug. Thus, the 10 lead molecules suggested in the present study would be of interest as promising starting point for designing antiviral compound against yellow fever.
Key wordsyellow fever virus envelope protein homology modeling virtual screening antiviral compound
Unable to display preview. Download preview PDF.
- Friesner, R.A., Banks, J.L., Murphy, R.B., Halgren, T.A., Klicic, J.J., Mainz, D.T., Repasky, M.P., Knoll, E.H., Shelley, M., Perry, J.K., Shaw, D.E., Francis, P., Shenkin, P.S. 2004. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47, 1739–1749.PubMedCrossRefGoogle Scholar
- Maestro v9.0, 2009. Schrodinger, LLC, Portland, OR.Google Scholar
- Monath, T.P. 1986. Pathology of the flaviviruses. In: Schlesinger, S., Schlesinger, M.J. (eds) The Togaviridae and Flaviviridae. Academic Press Inc, New York, 375–440.Google Scholar
- Oldstone, M.B.A. 2000. Viruses, Plagues, and History. Oxford University Press, UK.Google Scholar
- Rice, C.M. 1996. Flaviviridae: The viruses and their replication. In: Fields, B.N., Knipe, D.M., Howley, P.M. (eds) Lippincott-Raven Publishers, Philadelphia, 931–960.Google Scholar
- Rice, C.M., Strauss, J.H. 1986. Structure of the flavivirus genome. In: Schlesinger, S., Schlesinger, M.J. (eds), The Togaviridae and Flaviviridae. Academic Press Inc, New York, 279–326.Google Scholar
- Roehrig, J.T. 1997. Immunochemistry of the Dengue viruses. In: Gubler, D.J., Kuno, G. (eds), Dengue and Dengue Hemorrhagic Fever. CAB International, New York, 199–219.Google Scholar
- Schmaljohn, A.L., McClain, D. 1996. Alphaviruses (togaviridae) and flaviviruses (flaviviridae). In: Baron, S. (ed), Medical Microbiology. Univ of Texas Medical Branch.Google Scholar
- Sekhar, P.N., Reddy, L.A., De, Maeyer, M., Kumar, K.P., Srinivasulu, Y.S., Sunitha, M.S., Sphoorthi, I.S., Jayasree, G., Rao, A.M., Kothekar, V.S., Narayana, P.V., Kishor, P.B. 2009. Genome wide analysis and comparative docking studies of new diaryl furan derivatives against human cyclooxygenase-2, lipoxygenase, thromboxane synthase and prostacyclin synthase enzymes involved in inflammatory pathway. J Mol Graph Model 28, 313–329.PubMedCrossRefGoogle Scholar
- Umamaheswari, A., Pradhan, D., Hemanthkumar, M. 2010. Virtual screening for potential inhibitors of homology modeled Leptospira interrogans MurD ligase. J Chem Biol (in press). doi: 10.1007/s12154-010-0040-8.Google Scholar